• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Analyst: Mexico tariffs could hit some medical device makers harder

Analyst: Mexico tariffs could hit some medical device makers harder

June 3, 2019 By Brad Perriello

Nortech Systems Mexico
[Image courtesy of Google Maps]
Medical device companies that do significant business in Mexico could face stronger headwinds than their peers with less exposure south of the border if the Trump administration follows through on his threat to initiate tariffs this month, according to one medtech analyst.

Last week the president threatened to begin levying a 5% tariff on Mexican goods June 10, proposing to increase it by 5% every month until Mexico halts the flow of migrants to the U.S. border. Spooked by the threat, investors sent stock prices down across the globe May 31.

RBC Capital Markets analyst Brandon Henry said the effect of the tariffs would be moderate and easily weathered by the industry as a whole. But companies like ISRG and Medtronic that do a lot of business in Mexico could pay a stiffer price, Henry said.

“With China, the majority of companies in our space have reported a less than 1% earnings-per-share hit from the tariffs,” Henry wrote in a note to investors last week, according to Investor’s Business Daily.

“I think [Mexican tariffs are] going to be similar to [Chinese tariffs],” he told Barron’s. “I’ve heard back from a lot of the companies. I would describe it as a manageable impact for the space.”

Still, Mexico is key for the medtech industry, accounting for nearly $8 billion (15%) of the $50 billion import market and $3.5 billion in exports to Mexico. Before the trade war with China that country accounted for $6 billion in imports and $4 billion in exports, according to Henry.

“The U.S. medical device industry is heavily reliant on imported components from Mexico, which are used to assemble finished goods for either domestic consumption or for export to countries like Canada,” he wrote in the client note.

Companies with the most exposure to the proposed tariffs include Intuitive Surgical (NSDQ:ISRG), which makes most of the instruments for its da Vinci line of robot-assisted surgery devices in Mexicali, Mexico; Baxter (NYSE:BAX) and Integer Holdings (NYSE:ITGR), which three plants each there; Medtronic (NYSE:MDT), which has about 8% of its total manufacturing and research space in Mexico; and Becton Dickinson (NYSE:BDX), which responded to the Chinese tariffs by shifting operations to Mexico, Henry said.

“[BD] has also said that the biggest products the company had impacted in the first round of the Chinese tariffs were electromechanical devices,” Henry said. “Becton Dickinson has been protectively moving and validating to source those devices from Mexico.”

ISRG shares closed down -2.7% at $464.85 apiece May 31, the day after the Mexico tariff threat surfaced. BDX shares also closed down last week, at $233.44 each, off -1.6%. ITGR shares closed down -1.4% at $70.10 and BAX shares were out -1.3% at $73.44 when the market closed last week. Only MDT stocks failed to post a loss, closing flat at $92.58 per share.

Filed Under: Featured, Wall Street Beat

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy